EPIQ Partners’s CONMED CNMD Stock Holding History

EPIQ Partners’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$493K	Hold	15,059	–	–	0.21%	61
2026 Q1	$532K	Hold	15,059	–	–	0.25%	54
2025 Q4	$611K	Hold	15,059	–	–	0.29%	49
2025 Q3	$708K	Buy	15,059 +1,147	+8%	+$59.5K	0.33%	48
2025 Q2	$725K	Hold	13,912	–	–	0.37%	46
2025 Q1	$840K	Hold	13,912	–	–	0.44%	46
2024 Q4	$952K	Buy	13,912 +302	+2%	+$21K	0.52%	44
2024 Q3	$979K	Hold	13,610	–	–	0.54%	40
2024 Q2	$943K	Buy	13,610 +2,000	+17%	+$146K	0.64%	38
2024 Q1	$930K	Buy	11,610 +1,147	+11%	+$102K	0.62%	40
2023 Q4	$1.15M	Hold	10,463	–	–	0.82%	34
2023 Q3	$1.06M	Hold	10,463	–	–	0.8%	35
2023 Q2	$1.42M	Hold	10,463	–	–	0.97%	34
2023 Q1	$1.09M	Hold	10,463	–	–	0.75%	39
2022 Q4	$927K	Hold	10,463	–	–	0.62%	43
2022 Q3	$839K	Hold	10,463	–	–	0.52%	49
2022 Q2	$1M	Hold	10,463	–	–	0.61%	50
2022 Q1	$1.55M	Hold	10,463	–	–	0.84%	43
2021 Q4	$1.48M	Hold	10,463	–	–	0.79%	45
2021 Q3	$1.37M	Buy	+10,463	New	+$1.37M	0.63%	50

Other funds holding CNMD

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FAM

Fenimore Asset Management Cobleskill, New York $4.83B AUM 9.09% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

EPIQ Partners's CNMD Position: Q2 2026 in Review

EPIQ Partners held its CONMED (CNMD) position steady in Q2 2026 at 15,059 shares worth $493K. The position accounts for 0.21% of the portfolio, ranked #61.

EPIQ Partners first reported a position in CNMD in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.55M in Q1 2022. 23 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

EPIQ Partners held 15,059 shares of CONMED worth $493K as of Q2 2026.
EPIQ Partners left its CONMED share count unchanged in Q2 2026.
CONMED made up 0.21% of EPIQ Partners's portfolio in Q2 2026, its #61 holding.
EPIQ Partners first reported a position in CONMED in Q3 2021 and has held it in 20 quarters since.
EPIQ Partners's CONMED position peaked at $1.55M in Q1 2022.
23 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on EPIQ Partners's 13F filing for Q2 2026, filed 7 Jul 2026.